Financials

Overview

Mdxhealth operates on a calendar basis with its accounting year ending on Dec. 31. The company reports its consolidated financial statements under International Financial Reporting Standards (IFRS) and all amounts are in US Dollars. Mdxhealth publishes a consolidated and audited Annual Report on an annual basis, a consolidated Interim Report for its June 30 half-year financial figures, and business/financial updates at the end of Q1 and Q3.

Furthermore, for the Annual General Shareholders’ Meeting, the company also publishes the non-consolidated Belgian-GAAP financial statements of the parent company. Prior to October 5, 2010, mdxhealth operated under the name OncoMethylome Sciences.

Financial Reports

SEC Filings

Investor Relations Contact

For all investor related questions please call or email:

LifeSci Advisor (PR & IR)

US: +1.949.271.9223
ir@mdxhealth.com